Vanda Pharmaceuticals (VNDA) PT Raised to $27 at Oppenheimer, 'Near-term Stock Set-up Remains Solid'

Oppenheimer raised its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Next Articles